Us Drug Prices
-
{
- All
- News
-
US Drug Prices See Biggest Drop In 63 Years, Says Medicare Chief
US prescription drug prices are falling at their fastest rate in 63 years and are likely to decline further, the Trump administration's Medicare Chief said on Sunday.
-
Who Is Trump's "Brilliant, Overweight" Friend Behind Pharma Order? Internet Thinks It's Elon Musk
At a press event on Monday, announced a sweeping executive order aimed at slashing prescription drug prices in the US.
-
Trump Says He Has Signed New Executive Order To Lower Drug Prices
US President Donald Trump said on Sunday he had signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations.
-
U.S. Considers Concessions on Drug Protections in China Talks, Sources Say
Trump administration might give China a stronger mechanism to force down prices for some of the world’s most expensive drugs.
-
Drugmakers Reveal List Prices Online After Pressure From Trump
Manufacturers like Pfizer and Amgen have created new digital hubs where patients can find pricing information for multiple drugs.
-
Think Drugs Are Expensive in the U.S.? Just Try China
Beijing will want pharma companies to share the pain of the country’s growing healthcare costs.
-
Amazon-JPMorgan-Berkshire Health-Care Venture to Be Called Haven
Haven wants to improve access to primary care, simplify insurance and make prescription drugs more affordable.
-
FDA Chief Resigns After Clearing Slew of Drugs, Wrestling E-Cigs
A medical doctor, Gottlieb won over the agency’s staff and became a celebrated figure among pharmaceutical companies.
-
Drugmakers Dodge a Senate Bullet, Find Some Sympathy on Pricing
Many of the techniques the industry has used to preserve its profits from blockbuster drugs came in for criticism.
-
How Pharma Lost Its Edge in Washington
Major drug company CEOs are about to appear before Congress to address drug pricing—for the first time ever.
-
Trump Targets Drug Middlemen With `Devastating' Rebate Plan
HHS blasted the rebate system as “a hidden system of kickbacks to middlemen” that increases drug costs for Americans every day.
-
Big Pharma Lobby Group Spent Record Amount as Reform Push Grows
The pharmaceutical industry’s leading trade group disclosed that it had spent a record $27.5 million on lobbying in 2018.
-
Biggest Pharma Deal Ever Faces Aging Patents, Tough Politics
Shareholders from Celgene and Bristol-Myers will have to approve the deal, and there are early signs they have doubts.
-
Stock Investors Are Watching These Six Sectors Ahead of Midterms
Polls suggest Democrats will take House, GOP will keep Senate.
-
Trump Proposes Setting Some Drug Prices Using Global Index
Trump said he wanted to stop “global freeloading” by other governments through the proposed change to Medicare.
-
US Drug Prices See Biggest Drop In 63 Years, Says Medicare Chief
US prescription drug prices are falling at their fastest rate in 63 years and are likely to decline further, the Trump administration's Medicare Chief said on Sunday.
-
Who Is Trump's "Brilliant, Overweight" Friend Behind Pharma Order? Internet Thinks It's Elon Musk
At a press event on Monday, announced a sweeping executive order aimed at slashing prescription drug prices in the US.
-
Trump Says He Has Signed New Executive Order To Lower Drug Prices
US President Donald Trump said on Sunday he had signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations.
-
U.S. Considers Concessions on Drug Protections in China Talks, Sources Say
Trump administration might give China a stronger mechanism to force down prices for some of the world’s most expensive drugs.
-
Drugmakers Reveal List Prices Online After Pressure From Trump
Manufacturers like Pfizer and Amgen have created new digital hubs where patients can find pricing information for multiple drugs.
-
Think Drugs Are Expensive in the U.S.? Just Try China
Beijing will want pharma companies to share the pain of the country’s growing healthcare costs.
-
Amazon-JPMorgan-Berkshire Health-Care Venture to Be Called Haven
Haven wants to improve access to primary care, simplify insurance and make prescription drugs more affordable.
-
FDA Chief Resigns After Clearing Slew of Drugs, Wrestling E-Cigs
A medical doctor, Gottlieb won over the agency’s staff and became a celebrated figure among pharmaceutical companies.
-
Drugmakers Dodge a Senate Bullet, Find Some Sympathy on Pricing
Many of the techniques the industry has used to preserve its profits from blockbuster drugs came in for criticism.
-
How Pharma Lost Its Edge in Washington
Major drug company CEOs are about to appear before Congress to address drug pricing—for the first time ever.
-
Trump Targets Drug Middlemen With `Devastating' Rebate Plan
HHS blasted the rebate system as “a hidden system of kickbacks to middlemen” that increases drug costs for Americans every day.
-
Big Pharma Lobby Group Spent Record Amount as Reform Push Grows
The pharmaceutical industry’s leading trade group disclosed that it had spent a record $27.5 million on lobbying in 2018.
-
Biggest Pharma Deal Ever Faces Aging Patents, Tough Politics
Shareholders from Celgene and Bristol-Myers will have to approve the deal, and there are early signs they have doubts.
-
Stock Investors Are Watching These Six Sectors Ahead of Midterms
Polls suggest Democrats will take House, GOP will keep Senate.
-
Trump Proposes Setting Some Drug Prices Using Global Index
Trump said he wanted to stop “global freeloading” by other governments through the proposed change to Medicare.
